ISTANBUL, TURKEY / ACCESS Newswire / October 24, 2025 / Istanbul has rapidly become a global destination for dental implant ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / October 24, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective October 20, 2025, the Company granted 600 ...

VANCOUVER, BC / ACCESS Newswire / October 24, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, ...

The global market for disposable medical supplies is set for robust expansion. According to FutureWise Research’s latest ...

ALEXANDRIA, VA / ACCESS Newswire / October 24, 2025 / ASCP has introduced a new Age-Friendly Pharmacy (AFP) recognition, designed in partnership with the University of Maryland School of Pharmacy's ...

AUSTIN, TEXAS / ACCESS Newswire / October 24, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR, FORME and ...

Company advances digital technology initiatives with approval to publish applications on Apple's App Store MESA, ARIZONA / ACCESS Newswire / October 24, 2025 / Medical Care Technologies Inc. (OTC PINK ...

The global healthcare logistics market is anticipated to register a robust CAGR of around 8% between 2025 and 2030. Growth in the sector is primarily fueled by the escalating demand for time-critical ...

The Global AI in Medical Imaging Market is anticipated to expand at an impressive CAGR of nearly 28% over the next five years. This rapid growth is fueled by several factors, including the rising ...

The global restorative dentistry market is projected to grow steadily at a CAGR of around 6% during the forecast period. This growth is primarily fueled by an expanding elderly population, an upsurge ...

According to Acumen Research and Consulting, the global Personalized Medicine Biomarkers Market was valued at USD 20.95 billion in 2024 and is projected to reach USD 72.06 billion by 2033, growing at ...

Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration MIAMI, FLORIDA / ACCESS Newswire / ...